Your browser doesn't support javascript.
loading
CHALLENGES IN MANAGEMENT OF WARFARIN ANTI-COAGULATION IN ADVANCED HIV/AIDS PATIENTS WITH VENOUS THROMBOTIC EVENTS--A CASE SERIES FROM A RESEARCH CLINIC IN RURAL KERICHO, KENYA.
Tarus, N K; Pau, A K; Sereti, I; Kirui, F K; Sawe, F K; Agan, B K; Momanyi, L M; Ngeno, H C; Koskei, G K; Shaffer, D N.
Affiliation
  • Tarus NK; Kenya Medical Research Institute/Walter Reed Project, Kericho, Kenya.
East Afr Med J ; 90(7): 207-13, 2013 Jul.
Article in En | MEDLINE | ID: mdl-26862618
ABSTRACT

BACKGROUND:

Venous thrombotic events (VTE) occur at high ratesin HIV/AIDS patients and are likely under-diagnosed in rural sub-Saharan Africa.

OBJECTIVE:

To describe clinical presentations and challenges in the management of VTE in patients with advanced HIV/AIDS.

DESIGN:

Case series from patients enrolled in a prospective observational cohort study. SETTINGS A clinical research centre in rural Kericho, Kenya.

SUBJECTS:

Two hundred patients with median age 38 (30-47) years, BMI 16.9 (12.4-20.3) kg/m2, haemoglobin 9.3 (6.8-13.4) g/dL, CD4+ T-cell count 27 (4-77) cells/mm and plasma HIV RNA 5.23 (3.70-5.88) log10 copies/mL.

INTERVENTIONS:

VTE cases were diagnosed by clinical presentation and Doppler/ radiographic confirmation. Anti-coagulation therapy was managed by a multidisciplinary team; patients were initiated on enoxaparin or heparin followed by warfarin.

RESULTS:

Over two years,11patients (5.5%) experienced VTE. All but one (10/11,90.9%) case occurred within six months of starting ART. Nine patients had peripheral VTE (five popliteal, four femoral) and two had cerebral sinus thromboses. VTE was diagnosed 52 (1-469) days after ART initiation, and 81.8% of cases were outpatients at presentation. All patients received at least one concomitant medication that could significantly interact with warfarin (efavirenz, nevirapine, lopinavir/ritonavir, rifampicin, trimethoprim-sulfamethoxazole, and fluconazole). A median of 39 (10-180) days and eight (4-22) additional clinic visits were required to achieve/maintain a therapeutic INR of 2-3. Two minor bleeding complications occurred. No recurrent VTE cases were observed.

CONCLUSION:

Consideration of VTE and preparedness for management in patients with advanced HIV/AIDS starting ART is critical in sub-Saharan Africa. Overcoming challenges in anti-coagulation is possible in rural settings using a multidisciplinary team approach.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Patient Care Team / Warfarin / HIV Infections / Venous Thrombosis / Antiretroviral Therapy, Highly Active Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: East Afr Med J Year: 2013 Document type: Article Affiliation country: Kenya
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Patient Care Team / Warfarin / HIV Infections / Venous Thrombosis / Antiretroviral Therapy, Highly Active Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: East Afr Med J Year: 2013 Document type: Article Affiliation country: Kenya